- For Print
- May 9, 2009
Eisai confirms that it has the right to terminate the Strategic Alliance and Development Agreement with Pfizer with respect to Aricept® upon consummation of Pfizer's acquisition of Wyeth.
Eisai confirms that it has the right to terminate the Strategic Alliance and Development Agreement with Pfizer with respect to Aricept® upon consummation of Pfizer's acquisition of Wyeth.